I would like to give this a 5 star rating, but I cannot. Most of Dr. Belk's writings about the pharmacy industry are simply incorrect on their face, and as such the rating is negatively affected.
He argues that retail pharmacies are complicit in high prices, and that they are out to systematically gouge patients. The facts are quite the opposite. Pharmacies are bound by contracts by PBMs, which prohibit pharmacists from informing patients that a cash price might be less than using their insurance. Some states, like Ohio, have passed legislation that allows pharmacists to inform patients, while voiding those contractual terms. Moreover, he claims pharmacies receive kickbacks from PBMs, which again, is patently false. PBMs are the single-most detrimental institution that affects US drug costs.
What Dr. Belk left out, either by choice, misunderstanding or simply lack of researching the topic, is that PBMs regularly take back funds from pharmacies--often many months after a claim is paid--under Medicare Part D plans in the form of a DIR fee. The absence of these fees from his book dismayed me greatly, since these are the most detrimental fees that harm your community pharmacy.
Knowing that his research is incorrect about his book causes me to wonder about how well-researched his book is when detailing hospital and physician billing. I give him the benefit of the doubt, however, because of his standing of owning his medical practice.
I would encourage readers of this book to take at face-value the hospital and physician billing techniques, as well as his data about US health outcomes (as my own research has shown similar findings), but to do their own research about pharmacy issues. I would encourage Dr. Belk to conduct additional research into the retail pharmacy side for his subsequent editions.